A/Prof. Kris Kilian awarded $1.1 Million USD in research grant.

11 September 2020
A/Prof Kris Kilian has won a prestigious $1.1M USD grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) in the USA for his labs work in engineering melanoma tissue for drug discovery and development. Kris’s work was funded through the Cancer Tissue Engineering Collaborative (TEC) a network of scientists and engineers that aim to develop cancer tissue models in the laboratory to understand and treat a range of cancers.
His work involves malignant melanoma, and using synthetic materials to direct patient-derived melanoma cells in ways that can be studied to understand the disease, and to develop new drugs that are specific for a patient. Kris joins a network of 12 teams and is the first team outside of the USA. More details on his research below;
Title: Engineered microtumor arrays for development of combination therapies
Malignant melanoma is the most dangerous skin cancer, with a very poor survival rate once metastasis has occurred. Current treatments target the primary tumor and not the process of metastasis, and once the cancer has disseminated, chemotherapy has limited value. This project aims to integrate novel tissue engineered tumor mimics with patient derived tumor xenografts to explore progression towards patient-specific models for therapeutic development.
More information about the NCI Cancer Tissue Engineering Collaborative:
“I am absolutely thrilled to receive this award and to join this network of world leaders in cancer research. Considering Australia and New Zealand have the highest rate of melanoma globally, I think it is especially fitting to conduct this research down under. I look forward to taking part in the global fight against this deadly cancer” A/Prof Kris Kilian said. 
Please see the UNSW Newsroom for further details.